EMA accepts Marketing Authorization Application for lecanemab to treat early Alzheimer’s disease
BioArctic AB's partner Eisai says the European Medicines Agency (EMA) has accepted a marketing authorization…
BioArctic AB's partner Eisai says the European Medicines Agency (EMA) has accepted a marketing authorization…
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive…
A large clinical study is now beginning on an approved drug for treating psoriasis. The…
Phacilitate’s Advanced Therapies Week took place last week in Miami Beach, Florida. This week, we…
A research team from the LKS Faculty of Medicine, the University of Hong Kong (HKUMed)…
French biotech company Onxeo S.A. has given an update on the clinical development program of…
ExeGi Pharma LLC, which develops live biotherapeutic drugs and probiotics, says the FDA has cleared…
Orbsen Therapeutics Limited has announced what it says are encouraging headline interim results from the…
The World Health Organization (WHO) ranks antibiotic resistance as one of the top 10 threats…
A group of researchers from the Graduate School of Medicine at Nagoya University in Japan…
Atrogi AB, an early-stage Swedish pharma company, has announced that the first patient has been…
Sysnav Healthcare and Roche have partnered to develop industry standard outcome measurements in diseases associated…